Cited 0 times in
Predicting lymph node metastasis using preoperative parameters in patients with T1 ampulla of vater cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강창무 | - |
dc.contributor.author | 김경식 | - |
dc.contributor.author | 홍승수 | - |
dc.contributor.author | 황호경 | - |
dc.date.accessioned | 2024-12-06T03:55:24Z | - |
dc.date.available | 2024-12-06T03:55:24Z | - |
dc.date.issued | 2024-08 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/201288 | - |
dc.description.abstract | Background: Lymph node (LN) metastasis is an established prognostic factor for patients with surgically resected ampulla of Vater (AoV) cancer. The standard procedure for radical resection, including removal of regional LNs, is pancreaticoduodenectomy (PD); however, local excision has been considered as an alternative option for patients in the early stage cancer with significant comorbidities. In the present study, we elucidated the preoperative factors associated with LN metastasis to determine the appropriate surgical extent for T1 AoV cancer. Methods: We included patients who underwent surgery for T1 AoV cancer at Samsung Medical Center and Severance Hospital between 2000 and 2019. Risk factors were analyzed to identify the preoperative parameters associated with LN metastasis or regional LN recurrence during follow-up. Finally, using the identified risk factors, a prediction model was constructed. Results: Among 342 patients, 311 patients underwent PD, whereas 31 patients underwent transduodenal ampullectomy. Fourty-eight patients had LN metastasis according to pathology report, and two patients presented with regional LN recurrence. Age, carbohydrate antigen 19 − 9 (CA 19 − 9), and tumor differentiation were identified as factors associated with the increased risk of LN metastasis or regional LN recurrence. The area under the curve of the prediction model with these three factors was 0.728. Conclusion: Our newly developed prediction model using age, CA 19 − 9, and tumor differentiation can help select patients who require PD over local excision. Nevertheless, additional in-depth analysis is warranted to select appropriate surgical extent for patients with presumed T1 AoV cancer. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | BioMed Central | - |
dc.relation.isPartOf | BMC CANCER | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Aged, 80 and over | - |
dc.subject.MESH | Ampulla of Vater* / pathology | - |
dc.subject.MESH | Ampulla of Vater* / surgery | - |
dc.subject.MESH | CA-19-9 Antigen / blood | - |
dc.subject.MESH | Common Bile Duct Neoplasms* / pathology | - |
dc.subject.MESH | Common Bile Duct Neoplasms* / surgery | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Lymph Node Excision | - |
dc.subject.MESH | Lymph Nodes / pathology | - |
dc.subject.MESH | Lymph Nodes / surgery | - |
dc.subject.MESH | Lymphatic Metastasis* / pathology | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Neoplasm Recurrence, Local / pathology | - |
dc.subject.MESH | Neoplasm Staging | - |
dc.subject.MESH | Pancreaticoduodenectomy* | - |
dc.subject.MESH | Preoperative Period | - |
dc.subject.MESH | Prognosis | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Risk Factors | - |
dc.title | Predicting lymph node metastasis using preoperative parameters in patients with T1 ampulla of vater cancer | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Surgery (외과학교실) | - |
dc.contributor.googleauthor | So Jeong Yoon | - |
dc.contributor.googleauthor | Seung Soo Hong | - |
dc.contributor.googleauthor | Kee-Taek Jang | - |
dc.contributor.googleauthor | So Kyung Yoon | - |
dc.contributor.googleauthor | Hongbeom Kim | - |
dc.contributor.googleauthor | Sang Hyun Shin | - |
dc.contributor.googleauthor | Jin Seok Heo | - |
dc.contributor.googleauthor | Chang Moo Kang | - |
dc.contributor.googleauthor | Kyung Sik Kim | - |
dc.contributor.googleauthor | Ho Kyoung Hwang | - |
dc.contributor.googleauthor | In Woong Han | - |
dc.identifier.doi | 10.1186/s12885-024-12311-9 | - |
dc.contributor.localId | A00088 | - |
dc.contributor.localId | A00299 | - |
dc.contributor.localId | A05072 | - |
dc.contributor.localId | A04497 | - |
dc.relation.journalcode | J00351 | - |
dc.identifier.eissn | 1471-2407 | - |
dc.identifier.pmid | 39090569 | - |
dc.subject.keyword | Ampulla of vater cancer | - |
dc.subject.keyword | Ampullary cancer | - |
dc.subject.keyword | Lymph node metastasis | - |
dc.subject.keyword | Prognosis | - |
dc.contributor.alternativeName | Kang, Chang Moo | - |
dc.contributor.affiliatedAuthor | 강창무 | - |
dc.contributor.affiliatedAuthor | 김경식 | - |
dc.contributor.affiliatedAuthor | 홍승수 | - |
dc.contributor.affiliatedAuthor | 황호경 | - |
dc.citation.volume | 24 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 935 | - |
dc.identifier.bibliographicCitation | BMC CANCER, Vol.24(1) : 935, 2024-08 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.